10/21/2026
Psychedelics and Silicon Valley: A new frontier
Psychedelics shift from counterculture to tech industry darling, reshaping capitalism.
Topic archive
drug policy
6 stories
10/6/2026
FDA seeks public input on ibogaine research
A request for information asks researchers, clinicians and the public how ibogaine trials should be designed, dosed and monitored.
8/18/2026
Ibogaine's legal status in the US explained
Ibogaine remains illegal in the US despite its potential therapeutic benefits.
7/31/2026
Ibogaine research gains momentum in Mississippi
Mississippi explores ibogaine trials for addiction treatment, reflecting a shift towards health-centered drug policies.
7/24/2026
Joe Rogan's ibogaine advocacy sparks White House tension
Rogan's push for ibogaine approval led to conflict with a key Trump aide.
7/23/2026
Trump executive order boosts psychedelic therapy research
Order encourages psychedelic research, allocates $50M for state studies.